Maturation of apolipoprotein A-I: Unrecognized health benefit or a forgotten rudiment?

Journal of Lipid Research

Volumn 50, Issue 7, 2009, Pages 1257-1258

  Sviridov, Dmitri ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; BONE MORPHOGENETIC PROTEIN; HIGH DENSITY LIPOPROTEIN; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN C PROTEINASE ENHANCER 2 PROTEIN; UNCLASSIFIED DRUG;

ATHEROGENESIS; CHOLESTEROL TRANSPORT; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; MOLECULAR INTERACTION; NOTE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN POLYMORPHISM; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

APOLIPOPROTEIN A-I; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HEALTH; HUMANS; LIPOPROTEINS, HDL; PROTEIN PRECURSORS;

EID: 67650552675     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.E900003-JLR200     Document Type: Note

References (12)

1. Edelstein, C., J. I. Gordon, K. Toscas, H. F. Sims, A. W. Strauss, and A. M. Scanu. 1983. In vitro conversion of proapoprotein A-I to apoprotein A-I. Partial characterization of an extracellular enzyme activity. J. Biol. Chem. 258: 11430-11433.
2. Pyle, L., D. Sviridov, and N. Fidge. 2001. Characterization of the maturation of human pro-apolipoprotein A-I in an in vitro model. Biochemistry. 40: 3101-3108.
3. Chau, P., P. E. Fielding, and C. J. Fielding. 2007. Bone morphogenetic protein-1 (BMP-1) cleaves human proapolipoprotein A1 and regulates its activation for lipid binding. Biochemistry. 46: 8445-8450.
4. Zhu, J., J. Gardner, C. R. Pullinger, J. P. Kane, J. F. Thompson, and O. L. Francone. 2009. Regulation of apoAI processing by procollagen C-proteinase enhancer and bone morphogenetic protein-1. J. Lipid Res. 50: 1330-1339.
5. Pyle, L. E., N. H. Fidge, P. A. Barton, A. Luong, and D. Sviridov. 1997. Production of mature human apolipoprotein A-I in a baculovirusinsect cell system: propeptide is not essential for intracellular processing but may assist rapid secretion. Anal. Biochem. 253: 253-258.
6. Sviridov, D., A. Luong, L. Pyle, and N. Fidge. 1999. Effectivity of expression of mature forms of mutant human apolipoprotein A-I. Protein Expr. Purif. 17: 231-238.
7. Yvan-Charvet, L., M. Ranalletta, N. Wang, S. Han, N. Terasaka, R. Li, C. Welch, and A. R. Tall. 2007. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J. Clin. Invest. 117: 3900-3908.
8. Sviridov, D., L. Pyle, and N. Fidge. 1996. Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants. J. Biol. Chem. 271: 33277-33283.
9. Kono, M., Y. Okumura, M. Tanaka, D. Nguyen, P. Dhanasekaran, S. Lund-Katz, M. C. Phillips, and H. Saito. 2008. Conformational flexibility of the N-terminal domain of apolipoprotein A-I bound to spherical lipid particles. Biochemistry. 47: 11340-11347.
10. Powell, R., D. G. Higgins, J. Wolff, L. Byrnes, M. Stack, P. M. Sharp, and F. Gannon. 1991. The salmon gene encoding apolipoprotein A-I: cDNA sequence, tissue expression and evolution. Gene. 104: 155-161.
11. Vaughan, A. M., C. Tang, and J. F. Oram. 2009. ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation. J. Lipid Res. 50: 285-292.
12. Weinberg, R. 1994. Identification of functional domains in the plasma apolipoproteins by analysis of inter-species sequence variability. J. Lipid Res. 35: 2212-2222.